Agenda Backup
Our Scientific Program Committee has worked diligently to create a spectacular program of presentations, debates, and discussions with key speakers within the hypertension community and beyond. The program will highlight Basic Science, Clinical and Primary Care-Guidelines Implementation to address the most requested topics in hypertension and adjacent conditions for whole patient care.
PROGRAM OVERVIEW
Thursday, May 5, 2022
Time | Primary Care | Clinical/Pop Science | Basic Science | |
10:00 – 10:45 am ET |
Opening Plenary Hypertension and Covid-19 Speakers: Dr. Ernesto Schiffrin |
|||
11:00 – 12:00 am ET |
Topic #1: Guidelines and targets by population (including case studies) Topic #2: The new UK hypertension case finding program |
Hypertension and cardiovascular risk factors in people with severe mental illness: what are the implications?
Speaker: Dr. Ahmed Jérôme Romain |
Spatiotemporal and Functional Selectivity of G protein-Coupled Receptors Signaling; Impact in drug discovery.
Speaker: Dr. Michel Bouvier + 2 abstracts (15 mins x 2) |
|
12:00 – 12:15 pm ET | Break | |||
12:15 – 1:15 pm ET | Topic #1: Central Blood Pressure and Arterial Stiffness
Speaker: Dr. Ray Townsend |
Treatment of Heart Failure with Preserved Ejection Fraction (SGLT2 inhibitors) Speaker: Dr. Shelley Zieroth (30 mins) + 2 abstracts (15 mins x 2) |
Mechanistic insights into the benefits of exercise for hypertensive disorders of pregnancy
Speaker: Dr. Kristi Adamo + 2 abstracts (15 mins x 2) |
|
1:45 – 2:45 pm ET | Topic #1: Hypertension Complications – CKD, Ophthalmology, Dementia and Stroke (1hr panels) Speakers: Drs. Philip McFarlane, Jason Andrade, John Chen |
Renal Denervation
Speaker: Dr. Ray Townsend + 2 abstracts (15 mins x 2) |
Local Microvascular Blood Flow Regulation
Speaker: Dr. Graham Fraser + 2 abstracts (15 mins x 2) |
|
3:00 – 4:00 pm ET | 3 Rapid Fire Sessions (20 mins each) |
|||
4:00 – 4:15 pm ET | Break | |||
4:15 – 6:30 pm ET | Young Investigator Forum |
Friday, May 6, 2022
Time | Primary Care/Clinical/Pop Science | Basic Science | ||
10:00 – 10:45 am ET |
Plenary Obesity managements – Impact of lifestyle modifications on cardiometabolic health |
|||
11:00 – 12:00 am ET | Why do Canadian women have poorer hypertension (and other cardiovascular risk factor) control? Speakers: Drs. Paula Harvey, Stella Daskalopoulou, Colleen Norris (60 mins) |
Plant bioactives and the intersectionality of diet and pharmacotherapy in CVD Speaker: Dr. Pierre Haddad + 2 abstracts (15 mins x 2) |
||
12:00 – 12:15 pm ET | Break | |||
12:15 – 12:45 pm ET | SGLT2 INHIBITORS. New tool in treatment of hypertension? Speaker: Dr. Brendon Neuen |
|||
1:15 – 2:15 pm ET | Innovations in Blood Pressure Measurements (cuffless devices) Speaker: Dr. Daichi Shimbo + 2 abstracts (15 mins x 2) |
Updates on vascular complications in preeclampsia Speaker: Dr. Sandra Davidge + 2 abstracts (15 mins x 2) |
||
2:45 – 3:45 pm ET | Finerenone & Kidney and Heart Protection Speaker: Dr. Rajiv Agarwal + 2 abstracts (15 mins x 2) |
Urinary biomarkers of Mineralocorticoid activation Speaker: Dr. J. Matt Luther + 2 abstracts (15 mins x 2) |
||
4:00 – 6:00 pm ET | Young Investigator Forum |